Nanomedicine for Neurodegenerative Disorders

Selective Treatment Strategies
Herausgeber: Pathak, Kamla; Verma, Swati; Malviya, Rishabha

• Gebundenes Buch

Produktbeschreibung

Overviews various nanocarriers that encapsulate active compounds to treat NDs. Covers neurological disorders, clinical strategies for the management of neuro disorders, and the challenges in their treatment. Discusses specific techniques for treating NDs such as the delivery of RNA/DNA to the brain using nanoscience, etc.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: Apple Academic Press Inc.
• Seitenzahl: 500
• Erscheinungstermin: 7. Mai 2025
• Englisch
• Abmessung: 234mm x 156mm
• ISBN-13: 9781774916124
• ISBN-10: 1774916126
• Artikelnr.: 72506248

Autorenporträt

Rishabha Malviya, PhD, is Associate Professor of Pharmacy at the School of Medical and Allied Sciences at Galgotias University, Uttar Pradesh, India. He has authored more than 150 research and review papers for national and international journals of repute. He holds over 50 patents and has edited 13 books and authored 15 book chapters. His name has been included in the World's Top 2% Scientists list by Elsevier BV and Stanford University. He is reviewer, editor, and editorial board member of more than 50 national and international journals. Kamla Pathak, PhD, is Dean and Professor of Pharmacy at Uttar Pradesh University of Medical Sciences, Etawah, India. With teaching and research experience of more than 30 years, she has received many awards for her work. She has over 270 publications in journals of international and national repute. She also holds three patents and has authored four books and more than 20 book chapters. Professor Pathak has served as a member of the editorial advisory board of AAPS Pharm Sci Tech and is also a member of various professional bodies. She is also associated with the Indian pharmaceutical industry in the capacity of a scientific consultant. She has been listed in the top 2% of Indian scientists of the subsection Pharmacology and Pharmacy, in the World's Top 2% Scientists list. Swati Verma, MPharm, is working in the Department of Pharmacy at the School of Medical and Allied Sciences, Galgotias University, Uttar Pradesh, India. Her areas of interest are in computer-aided drug design, analytical chemistry, targeted drug delivery, and nanoformulation. She has authored four book chapters, edited two books, and many review papers published in international journals. She completed a BPharm at Dr. A.P.J. Abdul Kalam Technical University and MPharm (Pharmaceutical Chemistry) at Banasthali Vidyapith, Rajasthan, India. Her PhD work is in neurodisorders.

Inhaltsangabe

1. Neurodegenerative Disorders: Concepts, Types, and Treatment Strategies
2. Overview of the Blood-Brain Barrier (BBB) Transport Mechanisms 3.
Nanodiamonds as Emerging Nanotherapeutics for Brain-Targeted Drug Delivery
in the Management and Diagnosis of Neurodegenerative Disorders 4. The Real
Issue in Targeting Neurodegenerative Disease 5. Strategies to Cross the
Blood-Brain Barrier 6. Nanotechnology-Based Drug Delivery Systems for the
Treatment of Neurodegenerative Disorders 7. Nano Approaches Towards CNS
Drug Delivery 8. Current Trends in Drug-Nano Formulations Directed to the
Brain 9. Selection of an Appropriate Technique for Nano-Carrier
Preparation: A Multi-Criteria Decision-Making Methodology 10. Delivery of
RNA/DNA to the Brain Using Nanoscience 11. Application of Medicinal Plants
and Their Phytoconstituents Used in the Management of Neurodegenerative
Diseases 12. Molecular Mechanisms Underpinning Neuroprotection of
Nutritional Polyphenols 13. Implication of Herbal Nano-Formulations in the
Treatment of Neurological Disorders 14. Medical Laboratory Diagnosis of
Neurodegenerative Diseases Toward Adequate Treatment in Nanomedicine 15.
Role of Biomarkers in Detection, Diagnosis, and Prognosis of
Neurodegenerative Disorders 16. Use of Nano-Formulations in the Treatment
of Neurodegenerative Disorders 17. Nanostructured Drug Carriers for
Nose-to-Brain Drug Delivery in the Treatment of Neurological Disorders